Argent BioPharma inks deal to acquire AusCann assets and IP by Martin Lane August 19, 2025August 21, 2025 Argent BioPharma has entered into a binding agreement to acquire the core operating assets and intellectual […]
AusCann remains in holding pattern as proposed acquisition is delayed by Steve Jones May 1, 2023April 30, 2024
AusCann offloads 52% of CannPal to founder Layton Mills in move to ‘unlock potential’ of animal business by Steve Jones March 13, 2023April 30, 2024
Company news: Montu; Live Verdure; AusCann; Cann Global; MediPharm Labs; Zelira; Canopy Growth by Martin Lane November 4, 2021April 29, 2024
Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea by Martin Lane September 2, 2021April 26, 2024
AusCann starts Australian registration of skincare product for dogs by Martin Lane July 20, 2021April 26, 2024
‘Reputation arrives on foot, and leaves on horseback’: industry urged not to rush to profitability by Steve Jones March 18, 2021April 26, 2024
AusCann CEO Nick Woolf to step down once CannPal acquisition completes by Martin Lane January 11, 2021April 26, 2024
